Organogenesis (ORGO) - 2025 Q1 - Quarterly Results
Organogenesis (ORGO)2025-05-08 20:07Exhibit 99.1 First Quarter 2025 Financial Results: FOR IMMEDIATE RELEASE Organogenesis Holdings Inc. Reports First Quarter 2025 Financial Results CANTON, Mass., (May 8, 2025) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today reported financial results for the first quarter ended March 31, 2025. First Quarter 2025 Fi ...